AGTC APPLIED GENETIC TECHNOLOGIES

AGTC Joins the My Retina Tracker® Program as a New Scientific Collaborator

AGTC Joins the My Retina Tracker® Program as a New Scientific Collaborator
EN
07/10/2020

Underlying

AGTCAPPLIED GENETIC TECHNOLOGIES

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on APPLIED GENETIC TECHNOLOGIES

 PRESS RELEASE
Free
AGTC APPLIED GENETIC...

Beacon Therapeutics Announces Positive Phase 2 Interim 6-Month Data fr...

Beacon Therapeutics Announces Positive Phase 2 Interim 6-Month Data from DAWN Trial of Laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2025 Data showed improvements across several key measures of visual function, including low luminance visual acuity and microperimetry Laru-zova was generally well-tolerated by DAWN participants at 6 months LONDON and CAMBRIDGE, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a mission to save and restore the ...

May 6, 2025 1 EN
 PRESS RELEASE
Free
AGTC APPLIED GENETIC...

Syncona Limited Portfolio Company Successfully Completes Tender Offer ...

Syncona Limited Portfolio Company Successfully Completes Tender Offer and Acquisition of Applied Genetic Technologies Corporation GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today the successful completion of the previously announced tender offer (the “Offer”) to purchase all of the issued and outstanding shares of common stock of AGTC by a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”). The Offer, as extended, expired at 5:00 p.m., Eastern Time, on Nove...

December 1, 2022 1 EN
 PRESS RELEASE
Free
AGTC APPLIED GENETIC...

Syncona Limited Portfolio Company Extends Tender Offer to Acquire Appl...

Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today that a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”) has extended the expiration of its previously announced tender offer to purchase all of the issued and outstanding shares of AGTC common stock for $0.34 per share in cash at closing, plus up to an additional $0.73 per share payable pursuant to con...

November 29, 2022 1 EN
 PRESS RELEASE
Free
AGTC APPLIED GENETIC...

*FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by Nov...

*FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *FINAL REMINDER* GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC stockholders: A Syncona Limited portfolio company has commenced a tender offer to purchase all outstanding shares of AGTC common stock at a price per share of $0.34 in cash plus the right for AGTC stockholders to receive additional aggregate payments of up to $0.73 per share upon the achievement ...

November 28, 2022 1 EN
David Nierengarten ... (+2)
  • David Nierengarten
  • Dennis Pak
AGTC APPLIED GENETIC TECHNOLOGIES
11/25/22 November 25, 2022 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch